Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.

Prasongsook N, Kumar A, Chintakuntlawar AV, Foote RL, Kasperbauer J, Molina J, Garces Y, Ma D, Wittich MAN, Rubin J, Richardson R, Morris J, Hay I, Fatourechi V, McIver B, Ryder M, Thompson G, Grant C, Richards M, Sebo TJ, Rivera M, Suman V, Jenkins SM, Smallridge RC, Bible KC.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4506-4514. doi: 10.1210/jc.2017-01180.

PMID:
29029287
2.

Riedel's thyroiditis association with IgG4-related disease.

Stan MN, Sonawane V, Sebo TJ, Thapa P, Bahn RS.

Clin Endocrinol (Oxf). 2017 Mar;86(3):425-430. doi: 10.1111/cen.13238. Epub 2016 Oct 7.

PMID:
27647429
3.

Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Han PA, Kim HS, Cho S, Fazeli R, Najafian A, Khawaja H, McAlexander M, Dy B, Sorensen M, Aronova A, Sebo TJ, Giordano TJ, Fahey TJ 3rd, Thompson GB, Gauger PG, Somervell H, Bishop JA, Eshleman JR, Schneider EB, Witwer KW, Umbricht CB, Zeiger MA.

Thyroid. 2016 Apr;26(4):532-42. doi: 10.1089/thy.2015.0378. Epub 2016 Mar 7.

4.

Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence.

Hay ID, Johnson TR, Thompson GB, Sebo TJ, Reinalda MS.

Surgery. 2016 Jan;159(1):11-9. doi: 10.1016/j.surg.2015.05.046. Epub 2015 Oct 26.

PMID:
26514317
5.

The Value of Repeat Thyroid Fine-Needle Aspiration Biopsy in Patients with a Previously Benign Result: How Often Does It Alter Management?

Singh Ospina N, Sebo TJ, Morris JC, Castro MR.

Thyroid. 2015 Oct;25(10):1121-6. doi: 10.1089/thy.2015.0146. Epub 2015 Aug 17.

PMID:
26177342
6.

Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literature.

Singh Ospina N, Sebo TJ, Thompson GB, Clarke BL, Young WF Jr.

Clin Endocrinol (Oxf). 2014 Dec 31. doi: 10.1111/cen.12714. [Epub ahead of print]

PMID:
25557532
7.

The diagnostic utility of combination of HMGA2 and IMP3 qRT-PCR testing in thyroid neoplasms.

Jin L, Lloyd RV, Henry MR, Erickson LA, Sebo TJ, Rumilla KM, Zhang J.

Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):36-43. doi: 10.1097/PAI.0000000000000031.

PMID:
25356939
8.

Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy.

Stewart SB, Cheville JC, Sebo TJ, Frank I, Boorjian SA, Thompson RH, Gettman MT, Tollefson MK, Umbriet EC, Psutka SP, Bergstralh EJ, Rangel L, Karnes RJ.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):332-7. doi: 10.1038/pcan.2014.30. Epub 2014 Aug 26.

PMID:
25156060
9.

Review of our experience with neuroblastoma and ganglioneuroblastoma in adults.

Jrebi NY, Iqbal CW, Joliat GR, Sebo TJ, Farley DR.

World J Surg. 2014 Nov;38(11):2871-4. doi: 10.1007/s00268-014-2682-0.

PMID:
25002244
10.
11.

Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples.

Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J, Halling KC.

Cancer Cytopathol. 2014 Jun;122(6):459-67. doi: 10.1002/cncy.21414. Epub 2014 Mar 6.

12.

Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.

Tollefson MK, Karnes RJ, Kwon ED, Lohse CM, Rangel LJ, Mynderse LA, Cheville JC, Sebo TJ.

Mayo Clin Proc. 2014 Mar;89(3):308-18. doi: 10.1016/j.mayocp.2013.12.001. Epub 2014 Jan 31.

PMID:
24486077
13.

p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.

Zhong J, Ding L, Bohrer LR, Pan Y, Liu P, Zhang J, Sebo TJ, Karnes RJ, Tindall DJ, van Deursen J, Huang H.

Cancer Res. 2014 Mar 15;74(6):1870-1880. doi: 10.1158/0008-5472.CAN-13-2485. Epub 2014 Jan 30.

14.

Editorial review of ultrasound-guided fine-needle aspiration for solid thyroid nodules larger than 10 mm: correlation Thyroid nodules: team approach to a diagnostic and patient management challenge [corrected].

Sebo TJ.

Endocrine. 2014 Jun;46(2):173-4. doi: 10.1007/s12020-013-0138-1. Epub 2014 Jan 1. No abstract available. Erratum in: Endocrine. 2014 Jun;46(2):175.

PMID:
24381130
15.

Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.

Li C, Aragon Han P, Lee KC, Lee LC, Fox AC, Beninato T, Thiess M, Dy BM, Sebo TJ, Thompson GB, Grant CS, Giordano TJ, Gauger PG, Doherty GM, Fahey TJ 3rd, Bishop J, Eshleman JR, Umbricht CB, Schneider EB, Zeiger MA.

J Clin Endocrinol Metab. 2013 Sep;98(9):3702-12. doi: 10.1210/jc.2013-1584. Epub 2013 Aug 22.

PMID:
23969188
16.

Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation.

Brooks MD, Bennett RD, Weaver AL, Sebo TJ, Eckert SE, Strehler EE, Carr AB.

Int J Dent. 2013;2013:592843. doi: 10.1155/2013/592843. Epub 2013 Jul 8.

17.

Symptomatic amyloid goiters: report of five cases.

Law JH, Dean DS, Scheithauer B, Earnest F 4th, Sebo TJ, Fatourechi V.

Thyroid. 2013 Nov;23(11):1490-5. doi: 10.1089/thy.2012.0431. Epub 2013 Sep 19.

PMID:
23544771
18.

Application of vibro-acoustography in prostate tissue imaging.

Alizad A, Mehrmohammadi M, Mitri FG, Davis BJ, Sebo TJ, Mynderse LA, Kinnick RR, Greenleaf JF, Fatemi M.

Med Phys. 2013 Feb;40(2):022902. doi: 10.1118/1.4773890.

19.

Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout.

Bancos I, Grant CS, Nadeem S, Stan MN, Reading CC, Sebo TJ, Algeciras-Schimnich A, Singh RJ, Dean DS.

Endocr Pract. 2012 Jul-Aug;18(4):441-9. doi: 10.4158/EP11148.OR.

PMID:
22784830
20.

FOXL2 mutations in granulosa cell tumors occurring in males.

Lima JF, Jin L, de Araujo AR, Erikson-Johnson MR, Oliveira AM, Sebo TJ, Keeney GL, Medeiros F.

Arch Pathol Lab Med. 2012 Jul;136(7):825-8. doi: 10.5858/arpa.2011-0355-OA.

PMID:
22742556
21.

Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.

Kosari F, Cheville JC, Ida CM, Karnes RJ, Leontovich AA, Sebo TJ, Erdogan S, Rodriguez E, Murphy SJ, Vasmatzis G.

Am J Pathol. 2012 Jul;181(1):34-42. doi: 10.1016/j.ajpath.2012.03.043. Epub 2012 May 26.

22.

Renal oncocytoma growth rates before intervention.

Kurup AN, Thompson RH, Leibovich BC, Harmsen WS, Sebo TJ, Callstrom MR, Kawashima A, Atwell TD.

BJU Int. 2012 Nov;110(10):1444-8. doi: 10.1111/j.1464-410X.2012.011136.x. Epub 2012 Apr 23.

23.

What are the keys to successful thyroid FNA interpretation?

Sebo TJ.

Clin Endocrinol (Oxf). 2012 Jul;77(1):13-7. doi: 10.1111/j.1365-2265.2012.04404.x. Review.

PMID:
22469035
24.

RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.

Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV.

Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28.

25.

Comparison of methods to detect neoplasia in patients undergoing endoscopic ultrasound-guided fine-needle aspiration.

Levy MJ, Oberg TN, Campion MB, Clayton AC, Halling KC, Henry MR, Kipp BR, Sebo TJ, Zhang J, Enders FT, Clain JE, Gleeson FC, Rajan E, Roberts LR, Topazian MD, Wang KK, Gores GJ.

Gastroenterology. 2012 May;142(5):1112-1121.e2. doi: 10.1053/j.gastro.2012.02.002. Epub 2012 Feb 7.

PMID:
22326996
26.

Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.

Paner GP, Barkan GA, Mehta V, Sirintrapun SJ, Tsuzuki T, Sebo TJ, Jimenez RE.

Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c. Review.

PMID:
22301493
27.

Laparoscopic ultrasound-assisted liposuction for lymph node dissection: a pilot study.

Bonin EA, Mariani A, Swain J, Bingener J, Sumiyama K, Knipschield M, Sebo TJ, Gostout CJ.

Surg Endosc. 2012 Jul;26(7):1963-70. doi: 10.1007/s00464-011-2136-9. Epub 2012 Jan 19.

PMID:
22258298
28.

Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood.

Klee EW, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ, Bergen HR 3rd, Sebo TJ, Klee GG.

Clin Chem. 2012 Mar;58(3):599-609. doi: 10.1373/clinchem.2011.171637. Epub 2012 Jan 12.

29.

Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.

Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE.

Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.

PMID:
21572312
30.

Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008.

Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V.

Thyroid. 2011 Jul;21(7):765-72. doi: 10.1089/thy.2010.0453. Epub 2011 May 13.

PMID:
21568724
31.

HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.

Jin L, Lloyd RV, Nassar A, Lappinga PJ, Sebo TJ, Swartz K, Seys AR, Erickson-Johnson MR, Roth CW, Evers BR, Oliveira AM, Zhang J.

Diagn Mol Pathol. 2011 Jun;20(2):71-80. doi: 10.1097/PDM.0b013e3181ed784d.

PMID:
21532495
32.

The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status.

Karnes RJ, Cheville JC, Ida CM, Sebo TJ, Nair AA, Tang H, Munz JM, Kosari F, Vasmatzis G.

Cancer Res. 2010 Nov 15;70(22):8994-9002. doi: 10.1158/0008-5472.CAN-10-1358. Epub 2010 Nov 9.

33.

Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas.

Henrichsen TL, Reading CC, Charboneau JW, Donovan DJ, Sebo TJ, Hay ID.

J Clin Ultrasound. 2010 Sep;38(7):361-6. doi: 10.1002/jcu.20714.

PMID:
20533443
34.

Appendiceal carcinoid mimicking a Meckel's diverticulum on Tc-99m pertechnetate imaging.

Summers HG, Loftus EV Jr, Sebo TJ, Durski JM.

Clin Nucl Med. 2010 Apr;35(4):277-9. doi: 10.1097/RLU.0b013e3181d18fa2. No abstract available.

PMID:
20305424
35.

Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.

Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV.

Am J Surg Pathol. 2010 Jan;34(1):44-52. doi: 10.1097/PAS.0b013e3181c46677.

PMID:
19956062
36.

Fibroepithelial polyps of the ureter: a single-institutional experience.

Childs MA, Umbreit EC, Krambeck AE, Sebo TJ, Patterson DE, Gettman MT.

J Endourol. 2009 Sep;23(9):1415-9. doi: 10.1089/end.2009.0403.

PMID:
19715398
37.

Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.

Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC.

J Urol. 2009 Aug;182(2):517-25; discussion 525-7. doi: 10.1016/j.juro.2009.04.006. Epub 2009 Jun 13.

PMID:
19524984
38.

Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases.

Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, Rangel L, Blute ML, Sebo TJ, Tindall DJ, Kwon ED, Karnes RJ.

Clin Cancer Res. 2009 Mar 15;15(6):2174-80. doi: 10.1158/1078-0432.CCR-08-2262. Epub 2009 Mar 10.

39.

A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.

Fritcher EG, Kipp BR, Halling KC, Oberg TN, Bryant SC, Tarrell RF, Gores GJ, Levy MJ, Clayton AC, Sebo TJ, Roberts LR.

Gastroenterology. 2009 Jun;136(7):2180-6. doi: 10.1053/j.gastro.2009.02.040. Epub 2009 Feb 14.

PMID:
19232347
40.

Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer.

Kipp BR, Tanasescu M, Else TA, Bryant SC, Karnes RJ, Sebo TJ, Halling KC.

J Mol Diagn. 2009 Mar;11(2):148-54. doi: 10.2353/jmoldx.2009.080096. Epub 2009 Jan 29.

41.

Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation.

Brooks MD, Bennett RD, Strehler EE, Sebo TJ, Eckert SE, Carr AB.

J Prosthodont. 2009 Jan;18(1):11-6. doi: 10.1111/j.1532-849X.2008.00390.x.

PMID:
19166543
42.

Renal ischemia time in laparoscopic surgery: an experimental study in a porcine model.

Humphreys MR, Castle EP, Lohse CM, Sebo TJ, Leslie KO, Andrews PE.

Int J Urol. 2009 Jan;16(1):105-9. doi: 10.1111/j.1442-2042.2008.02173.x.

43.

Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.

Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR.

Surgery. 2008 Dec;144(6):980-7; discussion 987-8. doi: 10.1016/j.surg.2008.08.035.

PMID:
19041007
44.

Reliability of benign fine needle aspiration cytology of large thyroid nodules.

Porterfield JR Jr, Grant CS, Dean DS, Thompson GB, Farley DR, Richards ML, Reading CC, Charboneau JW, Vollrath BK, Sebo TJ.

Surgery. 2008 Dec;144(6):963-8; discussion 968-9. doi: 10.1016/j.surg.2008.09.006.

PMID:
19041004
45.

The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Sebo TJ, Blute ML.

J Urol. 2009 Jan;181(1):95-104; discussion 104. doi: 10.1016/j.juro.2008.09.016. Epub 2008 Nov 13.

PMID:
19012937
46.

Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.

Boorjian SA, Heemers HV, Frank I, Farmer SA, Schmidt LJ, Sebo TJ, Tindall DJ.

Endocr Relat Cancer. 2009 Mar;16(1):123-37. doi: 10.1677/ERC-08-0124. Epub 2008 Oct 9.

47.

Hyalinizing trabecular tumors of the thyroid gland are almost all benign.

Carney JA, Hirokawa M, Lloyd RV, Papotti M, Sebo TJ.

Am J Surg Pathol. 2008 Dec;32(12):1877-89. doi: 10.1097/PAS.0b013e31817a8f1b.

PMID:
18813121
48.

Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.

Kipp BR, Tyner HL, Campion MB, Voss JS, Karnes RJ, Sebo TJ, Halling KC, Zhang J.

Am J Clin Pathol. 2008 Oct;130(4):552-9. doi: 10.1309/DFJUHY3WPC9GUU2W.

PMID:
18794047
49.

Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.

Smoot RL, Zhang L, Sebo TJ, Que FG.

J Am Coll Surg. 2008 Sep;207(3):368-70. doi: 10.1016/j.jamcollsurg.2008.03.027. Epub 2008 May 15.

PMID:
18722942
50.

Changes in specimen preparation method may impact urine cytologic evaluation.

Voss JS, Kipp BR, Krueger AK, Clayton AC, Halling KC, Karnes RJ, Henry MR, Sebo TJ.

Am J Clin Pathol. 2008 Sep;130(3):428-33. doi: 10.1309/VP1XQ5GPQ687W1HU.

PMID:
18701417

Supplemental Content

Support Center